These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11403010)

  • 1. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Microbicide research-streamlining the process.
    Cates W
    AIDS; 2001 Feb; 15 Suppl 1():S64-5. PubMed ID: 11403010
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Microbicide research-streamlining the process, setting the stage.
    Gabelnick HL
    AIDS; 2001 Feb; 15 Suppl 1():S65-6. PubMed ID: 11407324
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues.
    Birnkrant D
    AIDS; 2001 Feb; 15 Suppl 1():S68-9. PubMed ID: 11407326
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Clinical trials and regulatory issues in developing countries.
    Rees H
    AIDS; 2001 Feb; 15 Suppl 1():S66-7. PubMed ID: 11407325
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of novel vaginal microbicides: from the bench to the clinic.
    Weber JN; Lacey CJ
    AIDS; 2001 Feb; 15 Suppl 1():S35-7. PubMed ID: 11403008
    [No Abstract]   [Full Text] [Related]  

  • 7. The ethics of testing microbicides: are we protecting the volunteers or the investigators?
    Potts M
    AIDS; 2001 Feb; 15 Suppl 1():S49-53. PubMed ID: 11403009
    [No Abstract]   [Full Text] [Related]  

  • 8. The development of vaginal microbicides for the prevention of HIV transmission.
    Weber J; Desai K; Darbyshire J;
    PLoS Med; 2005 May; 2(5):e142. PubMed ID: 15916473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in microbicide vaginal rings.
    Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
    Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological lessons from clinical trials and the future of microbicide research.
    van der Straten A; Montgomery ET; Hartmann M; Minnis A
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):89-102. PubMed ID: 23184582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbicides.
    McCormack S
    Curr Opin Infect Dis; 2002 Feb; 15(1):57-62. PubMed ID: 11964907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'HIV has a woman's face': vaginal microbicides and a case of ambiguous failure.
    Montgomery CM
    Anthropol Med; 2015 Dec; 22(3):250-62. PubMed ID: 26440223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicides and HIV: help or hindrance?
    Karmon E; Potts M; Getz WM
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):71-5. PubMed ID: 14501797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicide clinical trial adherence: insights for introduction.
    Woodsong C; MacQueen K; Amico KR; Friedland B; Gafos M; Mansoor L; Tolley E; McCormack S
    J Int AIDS Soc; 2013 Apr; 16(1):18505. PubMed ID: 23561044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update.
    Lard-Whiteford SL; Matecka D; O'Rear JJ; Yuen IS; Litterst C; Reichelderfer P;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):541-52. PubMed ID: 15097296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials of two microbicides to be launched in Africa.
    Pincock S
    BMJ; 2004 Apr; 328(7443):786. PubMed ID: 15070623
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of HIV microbicides: challenges and opportunities.
    Garg AB; Nuttall J; Romano J
    Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.
    Vallely A; Shagi C; Lees S; Shapiro K; Masanja J; Nikolau L; Kazimoto J; Soteli S; Moffat C; Changalucha J; McCormack S; Hayes RJ
    BMC Med Ethics; 2009 Oct; 10():17. PubMed ID: 19814830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.